+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2019 Update

  • ID: 4803999
  • Company Profile
  • July 2019
  • Region: Global
  • 37 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

Summary

Proteomics International Laboratories Ltd (Proteomics) is a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics developed PromarkerD, a predictive test for the diagnosis of diabetic kidney disease. Its analytical services include pharmacokinetic testing, biosimilars or biologic drug characterization, and proteome mapping. The company works on the discovery of painkillers and antibiotics drug compounds from animal venom. It serves the pharmaceutical industry across Australia. Proteomics is headquartered in Nedlands, Western Australia, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Proteomics International Laboratories Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Proteomics International Laboratories Ltd Company Overview
Proteomics International Laboratories Ltd Company Snapshot
Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
Proteomics International Laboratories Ltd – Pipeline Analysis Overview
Proteomics International Laboratories Ltd - Key Facts
Proteomics International Laboratories Ltd - Major Products and Services
Proteomics International Laboratories Ltd Pipeline Products by Development Stage
Proteomics International Laboratories Ltd Pipeline Products Overview
Diagnostic Test - Alzheimer's Disease
Diagnostic Test - Alzheimer's Disease Product Overview
Diagnostic Test - Asbestos Related Conditions
Diagnostic Test - Asbestos Related Conditions Product Overview
Diagnostic Test - Endometriosis
Diagnostic Test - Endometriosis Product Overview
Diagnostic Test - Lung Conditions
Diagnostic Test - Lung Conditions Product Overview
Diagnostic Test - Parasitic Infections
Diagnostic Test - Parasitic Infections Product Overview
PromarkerD
PromarkerD Product Overview
PromarkerD (CDx)
PromarkerD (CDx) Product Overview
PromarkerD LDT
PromarkerD LDT Product Overview
Proteomics International Laboratories Ltd - Key Competitors
Proteomics International Laboratories Ltd - Key Employees
Proteomics International Laboratories Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Proteomics International Laboratories Ltd, Recent Developments
Jun 07, 2019: PromarkerD to feature at American Diabetes Association 79th Scientific Sessions
Jun 03, 2019: Proteomics International to showcase PromarkerD at BIO International Convention
Apr 24, 2019: Proteomics International Laboratories: Quarterly business update for the year 2019
Feb 21, 2019: US patent granted for abnormal kidney function drug development using PromarkerD biomarker
Jan 30, 2019: Proteomics International Laboratories: Quarterly business update
Nov 09, 2018: PromarkerD kit version completed and ready for imminent commercial release
Sep 30, 2018: Proteomics International Laboratories: Quarterly business update
Apr 26, 2018: Proteomics International Laboratories: Quarterly Business Update
Apr 19, 2018: European PromarkerD patent granted for diabetic kidney disease covering 400 million people
Mar 20, 2018: PromarkerD Diagnostic Test Leader Officially Launched
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
  • Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
  • Proteomics International Laboratories Ltd Pipeline Products by Indication
  • Proteomics International Laboratories Ltd, Key Facts
  • Proteomics International Laboratories Ltd, Major Products and Services
  • Proteomics International Laboratories Ltd Number of Pipeline Products by Development Stage
  • Proteomics International Laboratories Ltd Pipeline Products Summary by Development Stage
  • Diagnostic Test - Alzheimer's Disease - Product Status
  • Diagnostic Test - Alzheimer's Disease - Product Description
  • Diagnostic Test - Asbestos Related Conditions - Product Status
  • Diagnostic Test - Asbestos Related Conditions - Product Description
  • Diagnostic Test - Endometriosis - Product Status
  • Diagnostic Test - Endometriosis - Product Description
  • Diagnostic Test - Lung Conditions - Product Status
  • Diagnostic Test - Lung Conditions - Product Description
  • Diagnostic Test - Parasitic Infections - Product Status
  • Diagnostic Test - Parasitic Infections - Product Description
  • PromarkerD - Product Status
  • PromarkerD - Product Description
  • PromarkerD (CDx) - Product Status
  • PromarkerD (CDx) - Product Description
  • PromarkerD LDT - Product Status
  • PromarkerD LDT - Product Description
  • Proteomics International Laboratories Ltd, Key Employees
  • Proteomics International Laboratories Ltd, Other Locations
  • Glossary
List of Figures
  • Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
  • Proteomics International Laboratories Ltd Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3
  • Sienna Cancer Diagnostics Ltd
  • Medtronic Australasia Pty Ltd
  • AusBiotech Ltd
Note: Product cover images may vary from those shown
Adroll
adroll